Green light for Oxford vaccine alongside domestic Covaxin hailed as ‘decisive turning point’ by PM
India has granted emergency approval to both the Oxford/AstraZeneca coronavirus vaccine and the domestically developed Covaxin, signalling the start one of the largest Covid-19 immunisation drives in the world.
At a press conference on Sunday, the drugs controller general of India said the decision to approve both the Oxford vaccine and Covaxin, which is produced by the Indian company Bharat Biotech and was part-funded by the government, had come after “careful examination” of the data.
